Winmark director awarded 356 stock options
WINMARK CORP director Percy C. Tomlinson Jr. received a grant of 356 Non-Employee Stock Options to buy common stock at an exercise price of $378.57 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
WINMARK CORP director Percy C. Tomlinson Jr. received a grant of 356 Non-Employee Stock Options to buy common stock at an exercise price of $378.57 per share. According to the footnote, the options vest 25% per year for four years starting on June 1, 2027.
After this grant, he holds 800 common shares directly and multiple outstanding option awards, including an option covering 5,400 underlying shares at a $242.58 exercise price expiring on December 14, 2031.
Insider Trade Summary
Grant/Award: 356 shares
Grant/Award
11 txns
Insider
Tomlinson Percy C Jr
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Employee Stock Option (right to buy) | 356 | $378.57 | $135K |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Employee Stock Option (right to buy) — 8,352 contracts for 7,996 underlying shares (Direct);
Common Stock — 800 shares (Direct)
Footnotes (1)
- F1. 25% per year for four years.
Key Figures
New option grant: 356 options
New option exercise price: $378.57 per share
Vesting schedule: 25% per year for four years
+4 more
7 metrics
New option grant
356 options
Non-Employee Stock Option grant on June 1, 2026
New option exercise price
$378.57 per share
Strike price for 356-option grant
Vesting schedule
25% per year for four years
Applies to new 356-option grant
Direct common shares
800 shares
Common stock directly owned after transactions
Largest existing option block
5,400 underlying shares
Non-Employee Stock Option at $242.58 exercise price
Largest option exercise price
$446.68 per share
Non-Employee Stock Option expiring December 11, 2033
Earliest major option expiration
December 14, 2031
Expiration for 5,400-share option at $242.58
Key Terms
Non-Employee Stock Option, exercise price, grant, award, or other acquisition, underlying security, +1 more
5 terms
Non-Employee Stock Option financial
"Non-Employee Stock Option (right to buy) with underlying common shares"
exercise price financial
"conversion_or_exercise_price of $378.5700 per share for the new grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant, award, or other acquisition financial
"transaction_code_description indicates Grant, award, or other acquisition"
underlying security financial
"underlying_security_title listed as Common Stock for each option"
expiration date financial
"expiration_date fields such as 2031-12-14T00:00:00.000Z for options"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Winmark (WINA) report for Percy C. Tomlinson Jr.?
Winmark reported that director Percy C. Tomlinson Jr. received a grant of 356 Non-Employee Stock Options. These options allow him to buy common shares at $378.57 each, vesting in four equal annual installments beginning June 1, 2027.
What is the exercise price and vesting schedule of the new Winmark (WINA) options?
The new Non-Employee Stock Option grant has a $378.57 exercise price per share. The footnote states it vests 25% per year for four years, starting June 1, 2027, creating a gradual, time-based compensation structure for the director.
What existing Winmark (WINA) option positions does the director retain?
The filing shows multiple outstanding Non-Employee Stock Options on Winmark common stock. These include an option relating to 5,400 underlying shares at a $242.58 exercise price, which is scheduled to expire on December 14, 2031, alongside several smaller grants at higher exercise prices.
Does the Winmark (WINA) Form 4 show any open-market stock purchases or sales?
The Form 4 data show a grant of 356 Non-Employee Stock Options coded as a grant or award. There are no transactions coded as open-market purchases or sales, and transaction summaries list zero buy and sell shares for this reporting period.
AI-generated analysis. How Rhea-AI works. Not financial advice.
